Table 2 Outcomes from included trials

From: Nutritional access routes following oesophagectomy—a systematic review

Study Route-related complications Route efficacy Nutritional markers Anastomotic leak Mortality Overall complications Hospital stay
   Duration of support (days) Conversion to alternate route      
Han-Geurts et al. (2007) Jej—39% overall, 11% removal/dislocation, 6% obstruction, 16% infection rate, 4% leakage, 1% leakage with relaparotomy. ND—28% overall, 25% removal/dislocation, 3% obstruction Jej—11 (2–126)
ND—10 (2–55) MR
Jej—5%
ND—8%
NR Jej—6%
ND—11%
Jej—8%
ND—3%
Jej—66%
ND—73%
14 d median both groups
Cooper et al. (2006) PPN—44% occluded, 31% re-sited, 12.5% phlebitis PPN—7 (4–10) PPN—19% NS—d 1–14–30, liver biochem elevated in all PPN group 0% PPN—0%
IvH—18% (30 d)
PPN—18.8%
IvH—27%
PPN—10 (5–25)
IvH—10 (6–60) MR
Shiraishi et al. (2005) NR NR NR NS—d 3, 5, 7, 10, 14 0% 0% Jej—13% Jej—24+/−6
PPN—21+/−3.4
Page et al. (2002) NJ—35% dislodgement NR Nil NS—d 0 and 7 0% 0% NJ—33%
IvH—33%
NJ—13.6+/−−5.2
IvH—13.4+/−5.0
Aiko et al. (2001) NR Not reported after d 7 NR NS to d 7, bilirubin, CRP higher in CLPNa and lymphocyte count higher in Jeja 0% 0% Jej—8%
CLPN—9%
Jej—34+/−4
CLPN—40+/−9
Gabor et al. (2005) NJ—sepsis 2%, 9% pneumonia, 2% wound infection, 20% dislocation
CLPN—sepsis 16%, 25% pneumonia, 9% wound infection
NR Nil NR NJ CPLN—48%,
CLPN—52%
NJ—7%
CLPN—9% (30d mortal)
NR NJ—26 (18–112)
CLPN—43 (30–140)a
  1. Abbreviations: CRP, C-reactive protein; CLPN, central line parenteral nutrition; d, day; IvH, intravenous hydration; Jej, jejunostomy; MR, median and range; ND, nasoduodenal; NJ, nasojenunal; NR, not reported PPN, peripheral parenteral nutrition.
  2. aStatistically significant difference.